Security News
Biocon Launches Denosumab Biosimilars
UnknownApr 23, 2026(12 days ago)
Biocon Launches Denosumab Biosimilars
On April 7, 2026, Biocon Limited announced that it had launched BOSAYA™ (denosumab-kyqq) and AUKELSO™ (denosumab-kyqq) in the United States. Both products are RANK ligand inhibitors used to treat conditions such as osteoporosis and cancer-related skeletal complications. ... By: Goodwin
Related News
Rare appeal may shed light on compensable time for remote employees
Unknownin about 10 hours
CFPB Finalizes New 1071 Small Business Lending Rule – Key Takeaways
Unknownabout 3 hours ago
Delaware Courts Sharpen Focus on Earn Outs: Review of Recent Case Law and Practical Guidance for Dealmakers
Unknownabout 3 hours ago